American Portfolios Advisors’s Blueprint Medicines BPMC Stock Holding History

American Portfolios Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$659	Hold	10	–	–	﹤0.01%	3347
2022 Q2	$505	Hold	10	–	–	﹤0.01%	3390
2022 Q1	$639	Hold	10	–	–	﹤0.01%	3431
2021 Q4	$1.07K	Hold	10	–	–	﹤0.01%	3315
2021 Q3	$1.03K	Hold	10	–	–	﹤0.01%	3297
2021 Q2	$880	Hold	10	–	–	﹤0.01%	3274
2021 Q1	$972	Hold	10	–	–	﹤0.01%	3139
2020 Q4	$1.12K	Buy	+10	New	+$1.05K	﹤0.01%	2818
2020 Q2	–	Sell	-25	Closed	-$1.46K	–	2848
2020 Q1	$1.46K	Buy	+25	New	+$1.61K	﹤0.01%	2482

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

American Portfolios Advisors's BPMC Position: Q3 2022 in Review

American Portfolios Advisors held its Blueprint Medicines (BPMC) position steady in Q3 2022 at 10 shares worth $659. The position accounts for ﹤0.01% of the portfolio, ranked #3347.

American Portfolios Advisors first reported a position in BPMC in Q1 2020 and has held it in 9 quarters since. The position peaked at $1.46K in Q1 2020. 240 funds tracked by Wall St. Rank hold BPMC as of Q3 2022.

American Portfolios Advisors held 10 shares of Blueprint Medicines worth $659 as of Q3 2022.
American Portfolios Advisors left its Blueprint Medicines share count unchanged in Q3 2022.
Blueprint Medicines made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3347 holding.
American Portfolios Advisors first reported a position in Blueprint Medicines in Q1 2020 and has held it in 9 quarters since.
American Portfolios Advisors's Blueprint Medicines position peaked at $1.46K in Q1 2020.
240 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.